Quantcast
Novavax’s COVID-19 shot receives provisional approval in New Zealand – Metro US

Novavax’s COVID-19 shot receives provisional approval in New Zealand

FILE PHOTO: Vials and medical syringe are seen in front
FILE PHOTO: Vials and medical syringe are seen in front of Novavax’s logo in this illustration

(Refiles to add media packaging code)

(Reuters) -Novavax Inc said on Thursday it had received provisional approval from New Zealand’s medicines regulator for its COVID-19 vaccine, Nuvaxovid, for individuals 18 years of age and older.

(Reporting by Amruta Khandekar; Editing by Anil D’Silva)